KR950008468A - 방향족 카복실산 유도체 - Google Patents

방향족 카복실산 유도체 Download PDF

Info

Publication number
KR950008468A
KR950008468A KR1019940021952A KR19940021952A KR950008468A KR 950008468 A KR950008468 A KR 950008468A KR 1019940021952 A KR1019940021952 A KR 1019940021952A KR 19940021952 A KR19940021952 A KR 19940021952A KR 950008468 A KR950008468 A KR 950008468A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
together form
carboxylic acid
acid derivatives
Prior art date
Application number
KR1019940021952A
Other languages
English (en)
Other versions
KR100335540B1 (ko
Inventor
클라우스 미카엘
모어 페터
Original Assignee
프리돌린 클라우스너·롤란드 보러
에프. 호프만-라 롯슈 아크티엔게젤샤프트
롤란드 보러
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프리돌린 클라우스너·롤란드 보러, 에프. 호프만-라 롯슈 아크티엔게젤샤프트, 롤란드 보러 filed Critical 프리돌린 클라우스너·롤란드 보러
Publication of KR950008468A publication Critical patent/KR950008468A/ko
Application granted granted Critical
Publication of KR100335540B1 publication Critical patent/KR100335540B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
    • C07C57/50—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid containing condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/66—Polycyclic acids with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/28—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/94—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

하기 일반식 (I)의 화합물은 약제, 구체적으로는 피부학적 및 종양학적 적용에 사용될 수 있다:
상기 식에서, R1은 상기 일반식(a) 또는 (b)의 잔기이고, R2-R10은 본 명세서에서 정의한 바와 같다.

Description

방향족 카복실산 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 하기 일반식 (I)의 화합물 및 일반식 (I)의 카복실산의 약학적으로 허용가능한 염:
    상기식에서, R1은 하기 일반식 (a) 또는 (b)의 잔기를 의미하고:
    R2는 C2-8-알카노일, C2-8-알킬, C2-8-알케닐, C2-8-알키닐 또는 -OCH2R3을 의미하고; R3은 수소, C1-6-알킬, C2-6-알케닐 또는 C2-6-알키닐을 의미하고; R4내지 R9는 각각 독립적으로 수소 또는 C1-5-알킬을 의미하거나; 또는 R8및 R9는 함께 (CRaRb)n를 형성하고, Ra및 Rb는 수소 또는 C1-5-알킬을 의미하고, n은 1, 2 또는 3을 의미하고, R4내지 R7은 상기 정의한 바와 같거나; 또는 R8및 R9는 함께 (CRaRb)n를 형성하고, R4및 R6은 함께 하이드록시에 의해 치환될 수 있는 메틸렌 또는 에틸렌을 형성하고, Ra, Rb, R5, R7및 n은 상기 정의한 바와 같고; R10은 카복실, C1-6-알콕시카보닐 또는 모노-또는 디-(C1-6-알킬)카바모일을 의미하고 일반식 (a)중의 점선으로 된 결합은 선택적이다.
  2. 제1항의 화합물 및 유용한 약학적 담체를 함유하는, 약학적 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940021952A 1993-09-02 1994-09-01 방향족카복실산유도체및이를포함하는약학적제제 KR100335540B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH2618/93 1993-09-02
CH261893 1993-09-02
CH196094 1994-06-21
CH1960/94 1994-06-21

Publications (2)

Publication Number Publication Date
KR950008468A true KR950008468A (ko) 1995-04-17
KR100335540B1 KR100335540B1 (ko) 2002-10-25

Family

ID=25689113

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940021952A KR100335540B1 (ko) 1993-09-02 1994-09-01 방향족카복실산유도체및이를포함하는약학적제제

Country Status (20)

Country Link
US (2) US5700836A (ko)
EP (1) EP0641759B1 (ko)
JP (1) JP2602629B2 (ko)
KR (1) KR100335540B1 (ko)
CN (1) CN1049423C (ko)
AT (1) ATE174322T1 (ko)
AU (1) AU680668B2 (ko)
CA (1) CA2129773C (ko)
CZ (1) CZ288426B6 (ko)
DE (1) DE59407431D1 (ko)
DK (1) DK0641759T3 (ko)
ES (1) ES2126684T3 (ko)
FI (1) FI113261B (ko)
GR (1) GR3029437T3 (ko)
HU (1) HU222345B1 (ko)
IL (1) IL110808A (ko)
NO (1) NO308579B1 (ko)
NZ (1) NZ264327A (ko)
RU (1) RU2130009C1 (ko)
UA (1) UA43317C2 (ko)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100353310B1 (ko) * 2000-03-27 2002-09-18 송웅재 축조용 돌묘
KR100385492B1 (ko) * 2000-08-10 2003-05-27 주식회사 지오지 파이프 연결 소켓 제조 방법

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
DE4320920C1 (de) * 1993-06-24 1994-06-16 Goldschmidt Ag Th Silane mit hydrophilen Gruppen, deren Herstellung und Verwendung als Tenside in wäßrigen Medien
FR2719041B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
US7115728B1 (en) * 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
KR100625255B1 (ko) * 1995-10-06 2008-01-30 리간드 파마슈티칼스 인코포레이티드 다이머-선택적rxr변조물질및그의사용방법
AU8588798A (en) 1997-07-25 1999-02-16 Institut Pasteur Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials
ATE413375T1 (de) * 2000-10-02 2008-11-15 Hoffmann La Roche Retinoide zur behandlung von emphysem
EP1935869A1 (en) * 2000-10-02 2008-06-25 F. Hoffmann-La Roche Ag Retinoids for the treatment of emphysema
JP4425628B2 (ja) * 2001-07-23 2010-03-03 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 細胞保護化合物、薬学的処方物および美容用処方物、ならびに方法
WO2005079463A2 (en) * 2004-02-17 2005-09-01 Dynamis Therapeutics, Inc. Fructoseamine 3 kinase and the formation of collagen and elastin
JP4683858B2 (ja) 2004-05-14 2011-05-18 スリーエム イノベイティブ プロパティズ カンパニー 物品支持具
EP2473596B1 (en) 2009-09-03 2017-12-13 Becton, Dickinson and Company Methods and compositions for direct chemical lysis
EP2613776B1 (en) 2010-09-01 2020-07-29 Thomas Jefferson University Composition and method for muscle repair and regeneration
WO2012076842A1 (en) * 2010-12-09 2012-06-14 University Of Durham Synthetic retinoids for control of cell differentiation
EP2736332A4 (en) * 2011-07-29 2015-03-18 Tempero Pharmaceuticals Inc CONNECTIONS AND METHODS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77254A1 (ko) * 1977-05-04 1979-01-18
DK159967C (da) * 1977-12-22 1991-06-03 Hoffmann La Roche Analogifremgangsmaade til fremstilling af terapeutisk aktive stilbenderivater
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
DE3202100A1 (de) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
ZA854828B (en) * 1984-07-27 1986-03-26 Hoffmann La Roche Phenyl nonatetraenoic acid derivatives
US4783549A (en) * 1984-09-05 1988-11-08 L'oreal Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
DE3434944A1 (de) * 1984-09-22 1986-04-03 Basf Ag, 6700 Ludwigshafen L-substituierte tetralinderivate, ihre herstellung und verwendung
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
CA1298309C (en) * 1987-11-06 1992-03-31 Michael Klaus Benzocycloheptene derivatives
ATE307795T1 (de) * 1992-04-22 2005-11-15 Ligand Pharm Inc Verbindungen mit retinoid x rezeptorselektivität
US5324840A (en) * 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
WO1995004036A1 (en) * 1993-01-11 1995-02-09 Ligand Pharmaceuticals Inc. Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100353310B1 (ko) * 2000-03-27 2002-09-18 송웅재 축조용 돌묘
KR100385492B1 (ko) * 2000-08-10 2003-05-27 주식회사 지오지 파이프 연결 소켓 제조 방법

Also Published As

Publication number Publication date
HU222345B1 (hu) 2003-06-28
NO308579B1 (no) 2000-10-02
KR100335540B1 (ko) 2002-10-25
US6610877B1 (en) 2003-08-26
ATE174322T1 (de) 1998-12-15
RU2130009C1 (ru) 1999-05-10
EP0641759B1 (de) 1998-12-09
IL110808A0 (en) 1994-11-11
DE59407431D1 (de) 1999-01-21
NO943232L (no) 1995-03-03
CZ288426B6 (en) 2001-06-13
JPH07112952A (ja) 1995-05-02
CA2129773A1 (en) 1995-03-03
FI113261B (fi) 2004-03-31
JP2602629B2 (ja) 1997-04-23
GR3029437T3 (en) 1999-05-28
RU94031754A (ru) 1996-07-20
CN1049423C (zh) 2000-02-16
NO943232D0 (no) 1994-09-01
DK0641759T3 (da) 1999-08-16
CZ210594A3 (en) 1995-06-14
IL110808A (en) 2003-03-12
AU680668B2 (en) 1997-08-07
US5700836A (en) 1997-12-23
HU9402480D0 (en) 1994-10-28
NZ264327A (en) 1996-02-27
FI944045A0 (fi) 1994-09-02
ES2126684T3 (es) 1999-04-01
FI944045A (fi) 1995-03-03
AU7148694A (en) 1995-03-16
EP0641759A1 (de) 1995-03-08
CN1105981A (zh) 1995-08-02
CA2129773C (en) 2007-05-01
HUT71473A (en) 1995-11-28
UA43317C2 (uk) 2001-12-17

Similar Documents

Publication Publication Date Title
KR950008468A (ko) 방향족 카복실산 유도체
NO940523L (no) Nye pyrazin-derivater
FI925734A (fi) Polyaspartamidderivat som adsorptionsmedel foer gallsyra, polyaspartamidderivat innehaollande gallsyror och foerfarande foer framstaellning av dessa samt anvaendning av dessa som laekemedel
DK0612731T3 (da) Nye quinolon- og naphthyridoncarboxylsyrederivater
NO942952L (no) 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike
MX9204318A (es) Complejos de derivados de pleuromutilina para su preparacion y composiciones farmaceuticas que los contienen.
ATE149165T1 (de) Stickstoff enthaltende bizyklische derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
NO843296L (no) Fremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet
ATE125538T1 (de) Thiochromanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE3768T1 (de) Furyl-nonatetraen-derivate und deren pharmazeutisch zulaessigen salze, verfahren zu ihrer herstellung, in diesen verfahren verwendete ausgangsstoffe, und sie enthaltende pharmazeutische zusammensetzungen.
KR940018351A (ko) 노나테트라에노산 유도체
ES2117114T3 (es) Nuevos derivados de tiaxolidin-diona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
DE69009604T2 (de) 2-Alkyliminobenzothiazoline, ihre Herstellung und sie enthaltende Arzneimittel.
FI860098A (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
IT1262565B (it) Disaccaridi di antracicline, loro processi di preparazione e composizioni farmaceutiche che li contengono.
DE69206321T2 (de) Ursane Derivate, ihre Herstellung und die enthaltende pharmazeutische Zusammensetzung.
RU2053228C1 (ru) Производные пептидов, способ их получения, фармацевтическая композиция, ингибирующая эластазу человеческих лейкоцитов
ATE74600T1 (de) Derivate von 5-(2-(1-pyrrolidinyl)-aethoxy>-pcymen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel.
NO933465D0 (no) Legemidler inneholdende 1,5,6,7-tetrahydro -4- indazol -4- on-derivater, nye 1,5,6,7 - tetrahydro -4- indazol -4- on-derivater, og fremgangsmaate for deres fremstilling

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20080331

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee